Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €106.50 | €112.40 | 5.537% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €115.20 | €130.00 | 12.847% |
| Acadia Pharmaceuticals | 35 | 1 | 0 | 0 | €14.62 | €29.92 | 104.620% |
| MacroGenics Inc. | 14 | 0 | 0 | 0 | €3.22 | €12.31 | 281.669% |
| Repligen Corp. | 14 | 0 | 0 | 0 | €130.90 | €180.11 | 37.594% |
| Biocryst Pharmaceuticals | 7 | 0 | 0 | 0 | €7.01 | €11.13 | 58.898% |
| Alnylam Pharmace. | 48 | 1 | 2 | 0 | €232.40 | €270.99 | 16.605% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €19.20 | €20.00 | 4.167% |
| TG Therapeutics Inc. | 20 | 1 | 0 | 0 | €21.35 | €31.12 | 45.812% |
| Eli Lilly Corp. | 69 | 0 | 2 | 0 | €817.10 | €829.73 | 1.545% |
| Sanofi S.A. ADR | 7 | 0 | 0 | 0 | €53.00 | €55.25 | 4.253% |
| Esperion Therapeutis.Inc. | 17 | 1 | 0 | 0 | €1.56 | €9.27 | 492.701% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| Dr. Reddy's Laboratories Ltd. ADR | 7 | 1 | 0 | 0 | €71.00 | €75.37 | 6.156% |
| Emergent Biosolutions Inc. | 9 | 2 | 0 | 0 | €6.99 | €7.44 | 6.525% |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €2.24 | €12.21 | 445.129% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €147.40 | €165.00 | 11.940% |
| Veracyte Inc. | 1 | 0 | 0 | 0 | €26.20 | - | - |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.74 | €10.00 | 167.380% |
| Adverum Biotechnologies Inc. | 10 | 0 | 0 | 0 | €1.38 | €25.32 | 1734.529% |
| ProQR Therapeutics N.V. | 7 | 2 | 0 | 0 | €1.71 | €2.32 | 35.719% |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €20.80 | - | - |
| Axsome Therapeutics Inc | 1 | 0 | 0 | 0 | €85.28 | €100.00 | 17.261% |
| Purple Biotech Ltd. ADR | 7 | 0 | 0 | 0 | €0.39 | €9.21 | 2236.802% |